Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus.

Diabetol Metab Syndr · 2015 · PMC4653899 · PMID 26594248

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, despite liver weights being significantly reduced in the NA/STZ/HFDT/Luseo as compared with NA/STZ/HFDT mice, the overall reduction in body weight was very slight and did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.